Goldman Sachs’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-255,362
| Closed | -$7.14M | – | 4448 |
|
|
2019
Q3 | $7.14M | Buy |
255,362
+237,523
| +1,331% | +$6.64M | ﹤0.01% | 2121 |
|
|
2019
Q2 | $252K | Sell |
17,839
-3,695
| -17% | -$52.2K | ﹤0.01% | 3780 |
|
|
2019
Q1 | $191K | Buy |
21,534
+4,902
| +29% | +$43.5K | ﹤0.01% | 3907 |
|
|
2018
Q4 | $126K | Sell |
16,632
-2,943
| -15% | -$22.3K | ﹤0.01% | 3852 |
|
|
2018
Q3 | $410K | Buy |
19,575
+2,329
| +14% | +$48.8K | ﹤0.01% | 3525 |
|
|
2018
Q2 | $516K | Buy |
17,246
+1,703
| +11% | +$51K | ﹤0.01% | 3508 |
|
|
2018
Q1 | $422K | Sell |
15,543
-466
| -3% | -$12.7K | ﹤0.01% | 3557 |
|
|
2017
Q4 | $461K | Buy |
+16,009
| New | +$461K | ﹤0.01% | 3485 |
|
|
2017
Q3 | – | Sell |
-22,100
| Closed | -$493K | – | 4501 |
|
|
2017
Q2 | $493K | Buy |
+22,100
| New | +$493K | ﹤0.01% | 3542 |
|